Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 2/20 | 0.53 |
| ▸ | OPRD1 | P41143 | 7/20 | 0.50 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.50 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.50 |
| ▸ | CTSC | P53634 | 2/20 | 0.49 |
| ▸ | MME | P08473 | 2/20 | 0.49 |
| ▸ | ACE | P12821 | 1/20 | 0.49 |
| ▸ | CPA1 | P15085 | 1/20 | 0.49 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | ANPEP | P15144 | 1/20 | 0.48 |
| ▸ | ECE1 | P42892 | 1/20 | 0.48 |
| ▸ | ALPI | P09923 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | XIAP | P98170 | 1/20 | 0.48 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30051265 | 1.00 | CTSD (0.53) | CTSDOPRD1OPRM1OPRK1CTSC | |
| SCHEMBL3052108 | 0.95 | CTSD (0.57) | CTSDCTSCMMEACECPA1 | |
| SCHEMBL3052110 | 0.95 | CTSD (0.57) | CTSDCTSCMMEACECPA1 | |
| SCHEMBL30050842 | 0.92 | CTSD (0.60) | CTSDCTSCMMEACECPA1 | |
| SCHEMBL31462339 | 0.92 | CTSD (0.60) | CTSDCTSCMMEACECPA1 | |
| SCHEMBL30714767 | 0.90 | OPRD1 (0.53) | OPRD1OPRM1OPRK1MMEACE | |
| SCHEMBL3202596 | 0.90 | CTSD (0.64) | CTSDCTSCMMEACECPA1 | |
| SCHEMBL30052367 | 0.90 | CTSD (0.58) | CTSDCTSCMMEACECPA1 | |
| SCHEMBL30050940 | 0.90 | CTSD (0.64) | CTSDCTSCMMEACECPA1 | |
| SCHEMBL30051904 | 0.89 | MME (0.57) | CTSDOPRD1OPRM1OPRK1MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11382956-B2 | Amylin analogues | ZEALAND PHARMA A/S (DK) | 2022-07-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11382956-B2 | Amylin analogues | IAPP, GLP1R, AMY2A | CTSD 830/4885OPRD1 2996/4885OPRM1 2772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.